Model
Edge
Apellis Pharmaceuticals Inc.
0001827317
Filing Type
144
Filing Date
1/12/2026
Updated
1/13/26, 2:12 PM
Copy Ref
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities